RT Journal Article
SR Electronic
T1 Back to Basics: Prioritizing Communication as a Key Instrument in Managing Rheumatoid Arthritis
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.210984
DO 10.3899/jrheum.210984
A1 Paul Studenic
A1 Helga Radner
YR 2021
UL http://www.jrheum.org/content/early/2021/09/26/jrheum.210984.abstract
AB Patients with rheumatoid arthritis (RA) have come to experience a tremendous increase in therapeutic options with disease-modifying antirheumatic drugs (DMARDs).1 After decades of dissatisfying drug therapy results with conventional synthetic DMARDs (csDMARDs) only, the introduction of the first tumor necrosis factor inhibitors in the late 1990s has revolutionized RA treatment.2